[
    [
        {
            "time": "",
            "original_text": "【光大医药 | 年报点评】云南白药：Q4收入端提速，“期权+回购”组合激励方案超预期",
            "features": {
                "keywords": [
                    "云南白药",
                    "Q4",
                    "收入端提速",
                    "期权",
                    "回购",
                    "激励方案"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【光大医药 | 年报点评】云南白药：Q4收入端提速，“期权+回购”组合激励方案超预期",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "云南白药（000538）：业绩增长平稳，新白药激励前行【2019年年报点评|西南医药朱国广/杜向阳团队】",
            "features": {
                "keywords": [
                    "云南白药",
                    "业绩增长",
                    "平稳",
                    "激励"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "云南白药（000538）：业绩增长平稳，新白药激励前行【2019年年报点评|西南医药朱国广/杜向阳团队】",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        }
    ]
]